Valk P - Search Results

1

Prospective investigation of positron emission tomography in lung nodules.

Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE. Lowe VJ, et al. Among authors: valk p. J Clin Oncol. 1998 Mar;16(3):1075-84. doi: 10.1200/JCO.1998.16.3.1075. J Clin Oncol. 1998. PMID: 9508193 Clinical Trial.

2

Analytical decision model for the cost-effective management of solitary pulmonary nodules.

Gambhir SS, Shepherd JE, Shah BD, Hart E, Hoh CK, Valk PE, Emi T, Phelps ME. Gambhir SS, et al. Among authors: valk pe. J Clin Oncol. 1998 Jun;16(6):2113-25. doi: 10.1200/JCO.1998.16.6.2113. J Clin Oncol. 1998. PMID: 9626211

3

Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J. Vranjesevic D, et al. J Nucl Med. 2002 Mar;43(3):325-9. J Nucl Med. 2002. PMID: 11884491 Free article.

4

Factors associated with false-positive staging of lung cancer by positron emission tomography.

Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds TR, Hopkins DM. Roberts PF, et al. Among authors: valk pe. Ann Thorac Surg. 2000 Oct;70(4):1154-9; discussion 1159-60. doi: 10.1016/s0003-4975(00)01769-0. Ann Thorac Surg. 2000. PMID: 11081861

5

The impact of PET on the management of lung cancer: the referring physician's perspective.

Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. Seltzer MA, et al. J Nucl Med. 2002 Jun;43(6):752-6. J Nucl Med. 2002. PMID: 12050318 Free article.

6

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.

Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J. Yap CS, et al. Among authors: valk pe. J Nucl Med. 2001 Sep;42(9):1334-7. J Nucl Med. 2001. PMID: 11535721 Free article.

7

Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.

Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. Meta J, et al. Among authors: valk p. J Nucl Med. 2001 Apr;42(4):586-90. J Nucl Med. 2001. PMID: 11337546 Free article.

8

Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.

Valk PE, Jagust WJ, Derenzo SE, Huesman RH, Geyer AB, Budinger TF. Valk PE, et al. Radiology. 1990 Sep;176(3):783-90. doi: 10.1148/radiology.176.3.2389037. Radiology. 1990. PMID: 2389037

9

Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.

Schöder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. Schöder H, et al. Among authors: valk pe. J Nucl Med. 2001 Aug;42(8):1139-43. J Nucl Med. 2001. PMID: 11483671 Free article. Clinical Trial.

10

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.

Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, Myers RW, Lutrin CL. Valk PE, et al. Ann Thorac Surg. 1995 Dec;60(6):1573-81; discussion 1581-2. doi: 10.1016/0003-4975(95)00752-0. Ann Thorac Surg. 1995. PMID: 8787446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters